Prior authorization requirements for Indiana MLTSS Pathways
Provides prior authorization requirements and submission instructions for participating UnitedHealthcare Community Plan of Indiana providers for a variety of services (inpatient, outpatient, DME, genetic testing, behavioral health, etc.). Applies to providers participating in Indiana MLTSS Pathways.
Effective July 1, 2024: For unclassified codes J3490, J3590 Lenmeldy will require prior authorization through Optum Transplant.
Effective April 1, 2025: Prior authorization required for Aucatzyl (C9301**).
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.